|
US5308850A
(en)
|
1991-09-30 |
1994-05-03 |
Merck Frosst Canada, Inc. |
(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
US5290798A
(en)
|
1991-09-30 |
1994-03-01 |
Merck Frosst Canada, Inc. |
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
JPH06145150A
(ja)
|
1992-11-09 |
1994-05-24 |
Kyowa Hakko Kogyo Co Ltd |
イミダゾール誘導体
|
|
AU4967797A
(en)
|
1996-11-19 |
1998-06-10 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzofuran derivatives
|
|
HUP9903330A2
(hu)
|
1996-11-19 |
2000-03-28 |
Amgen Inc. |
Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények
|
|
AU757059B2
(en)
|
1997-06-19 |
2003-01-30 |
Sepracor, Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
ATE499365T1
(de)
|
1997-10-24 |
2011-03-15 |
Nissan Chemical Ind Ltd |
Sulfamoyl-verbindungen und bakterizide für landwirtschaft oder gartenbau
|
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
CA2386750A1
(en)
|
1999-10-22 |
2001-05-03 |
Merck & Co. Inc. |
Pharmaceuticals for treating obesity
|
|
WO2002018335A1
(en)
|
2000-08-28 |
2002-03-07 |
Yamanouchi Pharmaceutical Co., Ltd. |
Cyclic amine derivatives
|
|
KR100823908B1
(ko)
|
2000-10-20 |
2008-04-21 |
바이오비트럼 에이비(피유비엘) |
2-, 3-, 4-, 또는 5-치환-ｎ1-(벤젠술포닐)인돌 및 이의치료 용도
|
|
EP1343756A2
(en)
|
2000-11-02 |
2003-09-17 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
US6503907B2
(en)
*
|
2000-11-28 |
2003-01-07 |
Hoffmann-La Roche Inc. |
Indole and dihydroindole derivatives
|
|
EA200300717A1
(ru)
|
2000-12-22 |
2003-12-25 |
Уайт |
Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
|
|
JP2005521721A
(ja)
|
2002-03-27 |
2005-07-21 |
スミスクライン・ビーチャム・コーポレイション |
酸およびエステル化合物ならびにその使用方法
|
|
MY135686A
(en)
|
2002-06-24 |
2008-06-30 |
Schering Corp |
Indole derivatives useful as histamine h3 antagonists
|
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
|
GB0323845D0
(en)
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
BRPI0507626A
(pt)
|
2004-02-11 |
2007-07-03 |
Irm Llc |
compostos e composiçoes como moduladores de lxr
|
|
WO2005085188A2
(en)
|
2004-03-02 |
2005-09-15 |
Compass Pharmaceuticals Llc |
Compounds and methods for anti-tumor therapy
|
|
MXPA06012683A
(es)
*
|
2004-05-03 |
2007-01-16 |
Hoffmann La Roche |
Derivados de indolilo como moduladores de receptor x del higado.
|
|
WO2005113499A1
(ja)
*
|
2004-05-20 |
2005-12-01 |
Sankyo Company, Limited |
インドール化合物
|
|
GT200500208A
(es)
*
|
2004-08-03 |
2006-03-02 |
|
Indazoles ùtiles para tratar enfermedades cardiovasculares
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
US20080319044A1
(en)
|
2004-11-01 |
2008-12-25 |
Nuada, Llc |
Compounds and Methods of Use Thereof
|
|
WO2006109633A1
(ja)
*
|
2005-04-07 |
2006-10-19 |
Daiichi Sankyo Company, Limited |
置換インドール化合物
|
|
FR2886293B1
(fr)
*
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
TW200745031A
(en)
*
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
|
CA2634235A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Combination of an h3 antagonist/inverse agonist and an appetite suppressant
|
|
ES2374581T3
(es)
|
2006-07-06 |
2012-02-20 |
Abbott Healthcare Products B.V. |
Derivados de azaindol con una combinación de agonismo parcial del receptor nicotínico de la acetilcolina e inhibición de la reabsorción de dopamina.
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
AU2008231789A1
(en)
|
2007-03-23 |
2008-10-02 |
Abbott Gmbh & Co. Kg |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
PT2142533E
(pt)
*
|
2007-03-30 |
2012-01-19 |
Hoffmann La Roche |
Derivados de imidazolidinona
|
|
GB0708141D0
(en)
*
|
2007-04-26 |
2007-06-06 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
|
RU2010111550A
(ru)
|
2007-08-29 |
2011-10-10 |
Шеринг Корпорейшн (US) |
2,3-замещенные индольные производные для лечения вирусных инфекций
|
|
EP2195317B1
(en)
|
2007-08-29 |
2012-01-18 |
Schering Corporation |
2,3-substituted azaindole derivatives for treating viral infections
|
|
US8765757B2
(en)
|
2007-11-16 |
2014-07-01 |
Merck Sharp & Dohme Corp. |
3-heterocyclic substituted indole derivatives and methods of use thereof
|
|
CN102317285A
(zh)
|
2007-11-16 |
2012-01-11 |
先灵公司 |
3-氨基磺酰基取代的吲哚衍生物及其使用方法
|
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
|
EP2245936A1
(en)
|
2009-04-27 |
2010-11-03 |
Bayer CropScience AG |
Use of 4-aza indole derivatives for the reduction of mycotoxin contamination
|
|
MX355042B
(es)
|
2009-06-08 |
2018-04-02 |
Acceleon Pharma Inc |
Metodos para aumentar adipositos termogenicos.
|
|
JP6055468B2
(ja)
|
2011-07-15 |
2016-12-27 |
ヴィーブ ヘルスケア ユーケー リミテッド |
アザインドール化合物及びｈｉｖを治療するための方法
|
|
US9988377B2
(en)
|
2011-08-24 |
2018-06-05 |
The Trustees Of Columbia University In The City Of New York |
Small molecule inducers of GDNF as potential new therapeutics for neuropsychiatric disorders
|
|
MX358696B
(es)
|
2011-12-22 |
2018-08-31 |
Connexios Life Sciences Pvt Ltd |
Derivados de aza adamantano y lo usos de los mismos.
|
|
KR20130142801A
(ko)
|
2012-06-20 |
2013-12-30 |
안국약품 주식회사 |
１１β－ＨＳＤ１ 효소의 억제활성을 갖는 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
WO2014065575A1
(ko)
|
2012-10-25 |
2014-05-01 |
주식회사유한양행 |
4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
|
|
WO2014085453A2
(en)
|
2012-11-29 |
2014-06-05 |
The Scripps Research Institute |
Small molecule lxr inverse agonists
|
|
JP6442475B2
(ja)
*
|
2013-03-15 |
2018-12-19 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｌｘｒ調節因子
|
|
EP2990403A1
(en)
|
2014-08-29 |
2016-03-02 |
Novartis Tiergesundheit AG |
Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
|
|
HK1243636A1
(zh)
|
2014-11-18 |
2018-07-20 |
Rutgers, The State University Of New Jersey |
用於治疗代谢疾病和癌症的新的线粒体解偶联剂
|
|
AR103232A1
(es)
|
2014-12-22 |
2017-04-26 |
Bristol Myers Squibb Co |
ANTAGONISTAS DE TGFbR
|
|
FR3037959B1
(fr)
*
|
2015-06-23 |
2017-08-04 |
Servier Lab |
Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
EP3458454B1
(en)
|
2016-05-18 |
2021-11-24 |
Rutgers, The State University of New Jersey |
2-hydroxy-n-(benzo[d]thiazol-2-yl)benzamide derivatives as mitochondrial uncouplers for the treatment of metabolic diseases and cancer
|
|
UY37659A
(es)
*
|
2017-04-10 |
2018-10-31 |
Phenex Fxr Gmbh |
Moduladores del receptor x del hígado (lxr)
|
|
TWI683808B
(zh)
*
|
2017-07-18 |
2020-02-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有胺或(硫)醯胺之lxr調節劑
|
|
DK3796975T3
(da)
|
2018-05-22 |
2023-12-04 |
Orsobio Inc |
Sulfonylaminobenzamidderivater
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
US20200397807A1
(en)
|
2019-06-18 |
2020-12-24 |
MitoPower, LLC |
Nicotinyl riboside compounds and their uses
|
|
JP2025540601A
(ja)
|
2022-11-03 |
2025-12-16 |
オルソバイオ， インコーポレイテッド |
脂質異常症を治療するための二環式のコア部分を有するｌｘｒ調節因子
|